Joint Statement of the German Radiological Society and the German Respiratory Society on a Quality-Assured Early Detection Program for Lung Cancer with Low-Dose CT^[*]

Abstract

Substantial new data on the early detection of lung cancer with low-dose CT has become available since the last joint statement of the German Radiological Society and the German Respiratory Society was published in 2011. The German S3 guideline on lung cancer was revised in 2018 and now contains a weak recommendation regarding the early detection of lung cancer with low-dose CT in a quality-assured early detection program. These new developments required a change in the position of the involved professional societies. This joint statement describes the main features of a quality-assured program for the early detection of lung cancer with low-dose CT in Germany.

Key points: 

• New study data on early detection of lung cancer with low-dose CT and the new German S3 guideline on lung cancer required a new positioning of the involved professional societies.

• The involved professional societies strongly recommend that low-dose CT examinations for early detection of lung cancer should only be performed within a quality-assured program.

• The article describes some fundamentals of such a quality-assured early detection program.

Citation Format

• Wormanns D, Kauczor H, Antoch G et al. Joint Statement of the German Radiological Society and the German Respiratory Society on a Quality-Assured Early Detection Program for Lung Cancer with Low-Dose CT. Fortschr Röntgenstr 2019; 191: 993 – 997

Key words

thorax - CT - screening

^* Published simultaneously in Pneumologie 2019; DOI: 10.1055/a-0984-8367

• Literatur

• 1 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms, Langversion 1.0, 2017, AWMF-Registernummer: 020/007OL. https://leitlinienprogramm-onkologie.de/Lungenkarzinom.98.0.html (Zugriff am 06.06.2019)
• 2 Kovalchik SA, Tammemagi M, Berg CD. et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013; 369: 245-254
• 3 Infante M, Sestini S, Galeone C. et al. Lung cancer screening with low-dose spiral computed tomography: Evidence from a pooled analysis of two Italian randomized trials. European journal of cancer prevention – the official journal of the European Cancer Prevention Organisation (ECP) 2017; 26: 324-329
• 4 De Koning HJ, Van Der Aalst CM, Ten Haaf K. et al. Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial. J Thorac Oncol 2018; 13: S185 . doi: 10.1016/j.jtho.2018.08.012
• 5 Becker N, Motsch E, Trotter A. et al. Lung cancer mortality reduction by LDCT screening – results from the randomised German LUSI trial. Int J Cancer 2019; (Epub ahead of print)
• 6 Nagel HD, Hering KG, Hieckel HG. et al. Protokollempfehlungen der AG DRauE zur Durchführung von Low-Dose-Volumen-HRCT-Untersuchungen der Lunge. Fortschr Röntgenstr 2017; 189: 553-567
• 7 https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADSAssessmentCategoriesv1-1.pdf (Zugriff am 06.06.2019)